438 related articles for article (PubMed ID: 15808407)
1. Induction of CYP1A1 and CYP1B1 and formation of carcinogen-DNA adducts in normal human mammary epithelial cells treated with benzo[a]pyrene.
Keshava C; Divi RL; Whipkey DL; Frye BL; McCanlies E; Kuo M; Poirier MC; Weston A
Cancer Lett; 2005 Apr; 221(2):213-24. PubMed ID: 15808407
[TBL] [Abstract][Full Text] [Related]
2. CYP1A1 and CYP1B1 gene expression and DNA adduct formation in normal human mammary epithelial cells exposed to benzo[a]pyrene in the absence or presence of chlorophyllin.
John K; Divi RL; Keshava C; Orozco CC; Schockley ME; Richardson DL; Poirier MC; Nath J; Weston A
Cancer Lett; 2010 Jun; 292(2):254-60. PubMed ID: 20163913
[TBL] [Abstract][Full Text] [Related]
3. Benzo(a)pyrene diolepoxide (BPDE)-DNA adduct levels in leukocytes of smokers in relation to polymorphism of CYP1A1, GSTM1, GSTP1, GSTT1, and mEH.
Lodovici M; Luceri C; Guglielmi F; Bacci C; Akpan V; Fonnesu ML; Boddi V; Dolara P
Cancer Epidemiol Biomarkers Prev; 2004 Aug; 13(8):1342-8. PubMed ID: 15298956
[TBL] [Abstract][Full Text] [Related]
4. High benzo[a]pyrene diol-epoxide DNA adduct levels in lung and blood cells from individuals with combined CYP1A1 MspI/Msp-GSTM1*0/*0 genotypes.
Rojas M; Alexandrov K; Cascorbi I; Brockmöller J; Likhachev A; Pozharisski K; Bouvier G; Auburtin G; Mayer L; Kopp-Schneider A; Roots I; Bartsch H
Pharmacogenetics; 1998 Apr; 8(2):109-18. PubMed ID: 10022748
[TBL] [Abstract][Full Text] [Related]
5. Chlorophyllin significantly reduces benzo[a]pyrene-DNA adduct formation and alters cytochrome P450 1A1 and 1B1 expression and EROD activity in normal human mammary epithelial cells.
Keshava C; Divi RL; Einem TL; Richardson DL; Leonard SL; Keshava N; Poirier MC; Weston A
Environ Mol Mutagen; 2009 Mar; 50(2):134-44. PubMed ID: 19152381
[TBL] [Abstract][Full Text] [Related]
6. Genetic polymorphisms in catalase and CYP1B1 determine DNA adduct formation by benzo(a)pyrene ex vivo.
Schults MA; Chiu RK; Nagle PW; Wilms LC; Kleinjans JC; van Schooten FJ; Godschalk RW
Mutagenesis; 2013 Mar; 28(2):181-5. PubMed ID: 23325794
[TBL] [Abstract][Full Text] [Related]
7. Modulation of benzo[a]pyrene diolepoxide-DNA adduct levels in human white blood cells by CYP1A1, GSTM1 and GSTT1 polymorphism.
Rojas M; Cascorbi I; Alexandrov K; Kriek E; Auburtin G; Mayer L; Kopp-Schneider A; Roots I; Bartsch H
Carcinogenesis; 2000 Jan; 21(1):35-41. PubMed ID: 10607731
[TBL] [Abstract][Full Text] [Related]
8. An association between BPDE-like DNA adduct levels and CYP1A1 and GSTM1 polymorphisma in pterygium.
Tung JN; Wu HH; Chiang CC; Tsai YY; Chou MC; Lee H; Cheng YW
Mol Vis; 2010 Apr; 16():623-9. PubMed ID: 20700368
[TBL] [Abstract][Full Text] [Related]
9. The resveratrol analogue, 2,3',4,5'-tetramethoxystilbene, does not inhibit CYP gene expression, enzyme activity and benzo[a]pyrene-DNA adduct formation in MCF-7 cells exposed to benzo[a]pyrene.
Einem Lindeman T; Poirier MC; Divi RL
Mutagenesis; 2011 Sep; 26(5):629-35. PubMed ID: 21669939
[TBL] [Abstract][Full Text] [Related]
10. Transcriptional signatures of environmentally relevant exposures in normal human mammary epithelial cells: benzo[a]pyrene.
Keshava C; Whipkey D; Weston A
Cancer Lett; 2005 Apr; 221(2):201-11. PubMed ID: 15808406
[TBL] [Abstract][Full Text] [Related]
11. Genetic polymorphisms in biotransformation enzymes for benzo[a]pyrene and related levels of benzo[a]pyrene-7,8-diol-9,10-epoxide-DNA adducts in Goeckerman therapy.
Beranek M; Fiala Z; Kremlacek J; Andrys C; Hamakova K; Chmelarova M; Palicka V; Borska L
Toxicol Lett; 2016 Jul; 255():47-51. PubMed ID: 27188524
[TBL] [Abstract][Full Text] [Related]
12. [Effects of CYP1A1 and GSTM1 gene polymorphisms and BPDE-DNA adducts on lung cancer].
Chen CM; Jin YT; Xu HY; Zhang CY; Zhang H; Zhang WM; Tan C; Sun XY
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2012 Feb; 29(1):23-7. PubMed ID: 22311486
[TBL] [Abstract][Full Text] [Related]
13. Correlation between CYP1A1 transcript, protein level, enzyme activity and DNA adduct formation in normal human mammary epithelial cell strains exposed to benzo[a]pyrene.
Divi RL; Lindeman TL; Shockley ME; Keshava C; Weston A; Poirier MC
Mutagenesis; 2014 Nov; 29(6):409-17. PubMed ID: 25245543
[TBL] [Abstract][Full Text] [Related]
14. BPDE-like DNA adduct level in oral tissue may act as a risk biomarker of oral cancer.
Chuang CY; Tung JN; Su MC; Wu BC; Hsin CH; Chen YJ; Yeh KT; Lee H; Cheng YW
Arch Oral Biol; 2013 Jan; 58(1):102-9. PubMed ID: 22809837
[TBL] [Abstract][Full Text] [Related]
15. Induction of Cyp1a1 and Cyp1b1 and formation of DNA adducts in C57BL/6, Balb/c, and F1 mice following in utero exposure to 3-methylcholanthrene.
Xu M; Nelson GB; Moore JE; McCoy TP; Dai J; Manderville RA; Ross JA; Miller MS
Toxicol Appl Pharmacol; 2005 Nov; 209(1):28-38. PubMed ID: 15885734
[TBL] [Abstract][Full Text] [Related]
16. CYP1A1 and GSTM1 genotypes affect benzo[a]pyrene DNA adducts in smokers' lung: comparison with aromatic/hydrophobic adduct formation.
Alexandrov K; Cascorbi I; Rojas M; Bouvier G; Kriek E; Bartsch H
Carcinogenesis; 2002 Dec; 23(12):1969-77. PubMed ID: 12507920
[TBL] [Abstract][Full Text] [Related]
17. GSTM1 null genotype as a risk factor for anti-BPDE-DNA adduct formation in mononuclear white blood cells of coke-oven workers.
Pavanello S; Siwinska E; Mielzynska D; Clonfero E
Mutat Res; 2004 Mar; 558(1-2):53-62. PubMed ID: 15036119
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of aryl hydrocarbon receptor transactivation and DNA adduct formation by CYP1 isoform-selective metabolic deactivation of benzo[a]pyrene.
Endo K; Uno S; Seki T; Ariga T; Kusumi Y; Mitsumata M; Yamada S; Makishima M
Toxicol Appl Pharmacol; 2008 Jul; 230(2):135-43. PubMed ID: 18372000
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory effects of chrysoeriol on DNA adduct formation with benzo[a]pyrene in MCF-7 breast cancer cells.
Takemura H; Nagayoshi H; Matsuda T; Sakakibara H; Morita M; Matsui A; Ohura T; Shimoi K
Toxicology; 2010; 274(1-3):42-8. PubMed ID: 20553787
[TBL] [Abstract][Full Text] [Related]
20. Aromatic DNA adducts and polymorphisms of CYP1A1, NAT2, and GSTM1 in breast cancer.
Firozi PF; Bondy ML; Sahin AA; Chang P; Lukmanji F; Singletary ES; Hassan MM; Li D
Carcinogenesis; 2002 Feb; 23(2):301-6. PubMed ID: 11872636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
